Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future randomized trials for non small-cell lung cancer.

M R Green1

  • 1Medical University of South Carolina, Charleston, South Carolina 29425, USA. greenmrk@musc.edu

Clinical Lung Cancer
|January 17, 2004
PubMed
Summary

Platinum-based chemotherapy is standard for advanced non-small-cell lung cancer. New trials compare standard regimens against novel combinations, three-drug therapies, and targeted agents for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvements in Survival and Clinical Benefit With Gemcitabine as First-Line Therapy for Patients With Advanced Pancreas Cancer: A Randomized Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

Matrix-assisted laser desorption/ionization-collision induced dissociation of poly(styrene).

Journal of the American Society for Mass Spectrometry·2016
Same author

Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.

Blood cancer journal·2015
Same author

BSACI guideline for the diagnosis and management of cow's milk allergy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2014
Same author

The importance of the abdominal X-radiograph in acute ulcerative colitis.

Archives of disease in childhood. Education and practice edition·2014
Same author

Peptide sequence determination by matrix-assisted laser desorption ionization employing a tandem double focusing magnetic-Orthogonal acceleration time-of-flight mass spectrometer.

Journal of the American Society for Mass Spectrometry·2013

Area of Science:

  • Medical Oncology
  • Clinical Trials
  • Lung Cancer Research

Background:

  • Platinum-based doublet chemotherapy is the current standard for advanced non-small-cell lung cancer (NSCLC).
  • Existing platinum-based regimens show similar efficacy in response rates and overall survival.
  • There is a need to explore novel therapeutic strategies to improve outcomes for NSCLC patients.

Purpose of the Study:

  • To review randomized phase III trials evaluating new treatment strategies for advanced non-small-cell lung cancer.
  • To highlight three distinct approaches being investigated in upcoming clinical trials.
  • To provide an overview of therapeutic advancements beyond standard platinum-based chemotherapy.

Main Methods:

  • Review of randomized phase III clinical trials.
  • Analysis of therapeutic strategies including new doublet combinations, three-drug regimens, and targeted agents.
  • Comparison of novel approaches against standard platinum-based chemotherapy.

Main Results:

  • Upcoming trials are evaluating three main strategies for advanced NSCLC.
  • Strategy 1: Head-to-head comparisons of new doublet combinations with standard platinum-based regimens.
  • Strategy 2: Investigating three-drug cytotoxic combinations versus two-drug standards.
  • Strategy 3: Adding molecular targeting agents to standard two-drug chemotherapy regimens.

Conclusions:

  • Multiple novel therapeutic strategies are under investigation for advanced non-small-cell lung cancer.
  • These strategies aim to improve upon the efficacy of current platinum-based chemotherapy.
  • Randomized trials are crucial for validating these new approaches in NSCLC treatment.

Related Experiment Videos